Cargando…

Emerging pharmacological therapies for ARDS: COVID-19 and beyond

ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and repair, and advances in supportive care, particularly ven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horie, Shahd, McNicholas, Bairbre, Rezoagli, Emanuele, Pham, Tài, Curley, Ger, McAuley, Danny, O’Kane, Cecilia, Nichol, Alistair, dos Santos, Claudia, Rocco, Patricia R. M., Bellani, Giacomo, Laffey, John G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Narrative Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352097/ https://www.ncbi.nlm.nih.gov/pubmed/32654006 http://dx.doi.org/10.1007/s00134-020-06141-z

Ejemplares similares

Death in hospital following ICU discharge: insights from the LUNG SAFE study
por: Madotto, Fabiana, et al.
Publicado: (2021)

Presence of comorbidities alters management and worsens outcome of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study
por: Rezoagli, Emanuele, et al.
Publicado: (2022)

Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies
por: McNicholas, Bairbre A., et al.
Publicado: (2023)

Correction : Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies
por: McNicholas, Bairbre A., et al.
Publicado: (2023)

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study
por: Madotto, Fabiana, et al.
Publicado: (2020)

Missed or delayed diagnosis of ARDS: a common and serious problem
por: Bellani, Giacomo, et al.
Publicado: (2020)

The Severe ARDS Generating Evidence (SAGE) Study: A Call for Action in the Daily Clinical Practice
por: Rezoagli, Emanuele, et al.
Publicado: (2021)

Lung–kidney cross-talk in the critically ill: insights from the Lung Safe study
por: Rezoagli, E., et al.
Publicado: (2020)

The LUNG SAFE study: a presentation of the prevalence of ARDS according to the Berlin Definition!
por: Bellani, Giacomo, et al.
Publicado: (2016)

Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database
por: Boyle, Andrew J., et al.
Publicado: (2018)

Pulmonary infections complicating ARDS
por: Luyt, Charles-Edouard, et al.
Publicado: (2020)

Evidence for chemokine synergy during neutrophil migration in ARDS
por: Williams, Andrew E, et al.
Publicado: (2017)

Current and evolving standards of care for patients with ARDS
por: Menk, Mario, et al.
Publicado: (2020)

Do Nonventilatory Strategies for Acute Lung Injury and ARDS Work?
por: Sweeney, Rob Mac, et al.
Publicado: (2010)

The Safety and Efficiency of Addressing ARDS Using Stem Cell Therapies in Clinical Trials
por: Rezoagli, Emanuele, et al.
Publicado: (2019)

Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies
por: Ware, Lorraine B., et al.
Publicado: (2020)

Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS
por: Jerath, Angela, et al.
Publicado: (2020)

Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS
por: Dutra Silva, Johnatas, et al.
Publicado: (2021)

Hyperoxaemia and hypoxaemia are associated with harm in patients with ARDS
por: Boyle, Andrew J., et al.
Publicado: (2021)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
por: Santhakumaran, Shalini, et al.
Publicado: (2019)

Spontaneous Breathing in Early Acute Respiratory Distress Syndrome: Insights From the Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE Study*
por: van Haren, Frank, et al.
Publicado: (2019)

When the Patient Says No
por: Curley, Brendan F.
Publicado: (2016)

Machine Learning Classifier Models: The Future for Acute Respiratory Distress Syndrome Phenotyping?
por: McNicholas, Bairbre, et al.
Publicado: (2020)

Awake prone positioning
por: McNicholas, Bairbre A., et al.
Publicado: (2022)

Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS
por: Grieco, Domenico Luca, et al.
Publicado: (2021)

How I set up positive end-expiratory pressure: evidence- and physiology-based!
por: Rezoagli, Emanuele, et al.
Publicado: (2019)

Validation of a tool for estimating clinician recognition of ARDS using data from the international LUNG SAFE study
por: Bechel, Meagan A., et al.
Publicado: (2023)

Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair
por: Fergie, Nicola, et al.
Publicado: (2019)

Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?
por: Curley, Gerard, et al.
Publicado: (2011)

Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial
por: Boyle, Andrew James, et al.
Publicado: (2022)

Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort
por: Goligher, Ewan C., et al.
Publicado: (2020)

Editorial: Lung monitoring in respiratory failure
por: Rezoagli, Emanuele, et al.
Publicado: (2023)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

Galectin-3 Inhibition in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2022)

Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS
por: Jackson, Megan V., et al.
Publicado: (2016)

Prone positioning in COVID-19 acute respiratory failure: just do it?
por: McNicholas, Bairbre, et al.
Publicado: (2020)

Pharmacological treatments in ARDS; a state-of-the-art update
por: Boyle, Andrew James, et al.
Publicado: (2013)

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial
por: Agus, A., et al.
Publicado: (2017)

Dance/Movement Therapy and the Arts in Healthcare: The First 50 Years
por: Goodill, Sherry W.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_85c51b87i933t4ujj5ein7jdso